lipid disorders

lipid disorders

altered levels of blood lipids, e.g. elevated levels of blood cholesterol, low-density lipoprotein and triglycerides; associated with increased risk of atherosclerosis, peripheral arterial disease, coronary artery disease and cerebral artery disease
References in periodicals archive ?
Such approaches may be more cost-effective in the long run than treating children with pharmacologic therapy after they develop obesity and lipid disorders.
It is mainly used in the treatment of primary hypercholesterolemia, mixed lipid disorders and pure elevated triglycerides.
Addressing all lipid disorders telephonically with nurse protocols certainly seems like fertile ground for exploration.
Akcea's most advanced program, volanesorsen, is in Phase 3 development to treat patients with ultra-orphan lipid disorders that are characterized by extremely high triglycerides and apoC-III, including familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy (FPL).
Lomitapide is a small molecule microsomal triglyceride transfer protein inhibitor being developed as an oral, once-a-day treatment for patients with severe lipid disorders.
Washington, Sept 27 (ANI): A new study has shown the association between lipid cell dysfunction and diseases such as obesity, diabetes and blood lipid disorders, a finding which may help combat metabolic diseases in future.
The researchers investigated what lies behind the development of lipid disorders in some obese people.
1475 - Lipoprotein test system - "Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.
Bipolar disorder is an independent risk factor for lipid disorders among patients without other known risk factors, according to a large, retrospective, managed care claims database study.
org), which is currently enrolling subjects for the treatment of HIV-associated lipodystrophy and lipid disorders (see page 12 for additional information).
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical development company focused on new therapies for the treatment of cardiovascular, metabolic and endocrine diseases, recently announced that it has acquired exclusive worldwide rights to a novel, orally-active compound for the treatment of lipid disorders and obesity.
The sustaining therapeutic technologies--think of statins for treating lipid disorders, computer modeling for providing precise dosimetry in radiation oncology, SSRI (seratonin re-uptake inhibitors) for depression, chemotherapy tailored to the biology of the cancer or even two-lead biventricular cardiac pacemakers for heart failure.